Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Author:

Cohen Ezra E W,Soulières Denis,Le Tourneau Christophe,Dinis José,Licitra Lisa,Ahn Myung-Ju,Soria Ainara,Machiels Jean-Pascal,Mach Nicolas,Mehra Ranee,Burtness Barbara,Zhang Pingye,Cheng Jonathan,Swaby Ramona F,Harrington Kevin J,Acosta-Rivera Mirelis,Adkins Douglas R.,Aghmesheh Morteza,Ahn Myung-Ju,Airoldi Mario,Aleknavicius Eduardas,Al-Farhat Yousuf,Algazi Alain P.,Almokadem Salah,Alyasova Anna,Bauman Jessica R.,Benasso Marco,Berrocal Alfonso,Bray Victoria,Burtness Barbara Ann,Caponigro Francesco,Castro Ana,Cescon Terrence P.,Chan Kelvin,Chaudhry Arvind,Chauffert Bruno,Cohen Ezra,Csoszi Tibor,De Boer J.P.,Delord Jean-Pierre,Dietz Andreas,Dinis Jose,Dupuis Charlotte,Digue Laurence,Erfan Jozsef,Escobar Alvarez Yolanda,Evans Mererid,Fidler Mary Jo,Forster Martin David,Friesland Signe,Ganti Apar K.,Geoffrois Lionnel,Grant Cliona,Gruenwald Viktor,Harrington Kevin,Hoffmann Thomas,Horvai Geza,Inciura Arturas,Jang Raymond,Jankowska Petra,Jimeno Antonio,Joseph Mano,Juarez Ramiro Alejandro,Karaszewska Boguslawa,Kawecki Andrzej,Keilholz Ulrich,Keller Ulrich,Kim Sung-Bae,Kocsis Judit,Kotecki Nuria,Kozloff Mark F.,Lambea Julio,Landherr Laszlo,Lantsukhay Yuri,Lazarev Sergey Alexandrovich,Lee Lip Way,Le Tourneau Christophe,Licitra Lisa,Lifirenko Igor Dmitrievich,Mach Nicolas,Martincic Danko,Matorin Oleg Vladmirovhich,McGrath Margaret,Machiels Jean-Pascal,Mehra Ranee,Misiukiewicz Krzysztof,Morris John C.,Mufazalov Fagim Fanisovich,Niu Jiaxin,Pamoorthy Srinivasan Devraj,Perez Segura Pedro,Rauch Daniel,Ribeiro Maria Leonor,Rodriguez Cristina,Rolland Frederic,Russo Antonio,Ruzsa Agnes,Sanches Frederico,Shin Sang-Won,Shtiveland Mikhail,Soulieres Denis,Soria Ainara,Specenier Pol,Szekanecz Eva,Szota Judit,van Herpen Carla M.L.,Velez-Cortes Hector A.,Walsh William V.,Wilop Stefan,Winterhalder Ralph,Wojtukiewicz Marek,Wong Deborah,Zandberg Dan

Publisher

Elsevier BV

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3